Donald N Halbert
Overview
Explore the profile of Donald N Halbert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
757
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hsu H, Chan S, Sobell D, Halbert D, Groody E
J Food Prot
. 2019 May;
54(4):249-255.
PMID: 31051629
A colorimetric DNA hybridization assay has been developed for the rapid detection of Escherichia coli in foods. The method employs two oligonucleotide probes which are specific for the 16S ribosomal...
2.
Shi L, Campbell G, Jones W, Campagne F, Wen Z, Walker S, et al.
Nat Biotechnol
. 2010 Aug;
28(8):827-38.
PMID: 20676074
Gene expression data from microarrays are being applied to predict preclinical and clinical endpoints, but the reliability of these predictions has not been established. In the MAQC-II project, 36 independent...
3.
Fielden M, Nie A, McMillian M, Elangbam C, Trela B, Yang Y, et al.
Toxicol Sci
. 2008 Feb;
103(1):28-34.
PMID: 18281259
The Critical Path Institute recently established the Predictive Safety Testing Consortium, a collaboration between several companies and the U.S. Food and Drug Administration, aimed at evaluating and qualifying biomarkers for...
4.
Fielden M, Halbert D
Pharmacogenomics
. 2007 Mar;
8(4):401-5.
PMID: 17391077
Iconix Biosciences has developed leading products and services that apply novel and proprietary genomic technologies to profile candidate drug compounds in early discovery through to preclinical development, leading to a...
5.
Ganter B, Snyder R, Halbert D, Lee M
Pharmacogenomics
. 2006 Oct;
7(7):1025-44.
PMID: 17054413
A range of genomics technologies are increasingly becoming integrated with existing scientific disciplines to broaden and strengthen existing capabilities and open new avenues of research in drug discovery and development....
6.
Semizarov D, Frost L, Sarthy A, Kroeger P, Halbert D, Fesik S
Proc Natl Acad Sci U S A
. 2003 May;
100(11):6347-52.
PMID: 12746500
Short interfering RNA (siRNA) is widely used for studying gene function and holds great promise as a tool for validating drug targets and treating disease. A critical assumption in these...
7.
Haasch D, Chen Y, Reilly R, Chiou X, Koterski S, Smith M, et al.
Cell Immunol
. 2002 Nov;
217(1-2):78-86.
PMID: 12426003
In a search for novel early T cell activation transcripts, we identified expressed sequence tags (ESTs) more abundantly expressed in normal human CD4(+) T lymphocytes fully activated by a 5...
8.
Waring J, Halbert D
Curr Opin Mol Ther
. 2002 Jul;
4(3):229-35.
PMID: 12139308
As human genetics and genomics have progressed, culminating in the completion of the rough draft of the human genome in February 2001, new tools and technologies have been developed to...